FDAnews Drug Daily Bulletin

VIOQUEST TO HOST ANALYST MEETING

May 23, 2006
A A

VioQuest Pharmaceuticals, Inc. is hosting an analyst meeting to build awareness of the effects of the over-expression of phosphorylated Akt and PTPases, and their roles in cancer treatment. "Optimizing Cancer Treatment With Drugs That Target Critical Cellular Pathways" will be held Wednesday, May 24, 2006, at the Intercontinental, The Barclay New York, in New York City beginning at 4:30 PM EDT.
PrimeZone